Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -49.08% is 153% below its 5-year average of -19.37%, near the low end of its 5-year range (-49.08%–-6.25%).
As of the fiscal period ended Tuesday, June 30, 2026. 34.74% below its 12-month average of -36.43%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -49.08%.
RETURN ON INVESTED CAPITAL (ROIC)
-49.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-36.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-23.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-19.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-26.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-34.74%
CURRENT VS 3Y AVG
-109.82%
CURRENT VS 5Y AVG
-153.33%
CURRENT VS 10Y AVG
-85.70%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 768 covered companies
CURRENT VS SECTOR MEDIAN
-42.53%
vs the sector median at left
Quanterix Corporation
Market Cap
$163.22M
Return on Invested Capital (ROIC)
-49.08%
TTM Avg
-36.43%
3Y Avg
-23.39%
5Y Avg
-19.37%
Market Cap
$162.60M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-138.87%
3Y Avg
-97.17%
5Y Avg
-81.85%
Market Cap
$161.52M
Return on Invested Capital (ROIC)
-57.59%
TTM Avg
-65.44%
3Y Avg
-58.20%
5Y Avg
-45.38%
Market Cap
$166.08M
Return on Invested Capital (ROIC)
4.92%
TTM Avg
-1.65%
3Y Avg
-7.20%
5Y Avg
-5.46%
Market Cap
$159.52M
Return on Invested Capital (ROIC)
-135.38%
TTM Avg
-110.80%
3Y Avg
-91.23%
5Y Avg
-65.73%
Market Cap
$158.63M
Return on Invested Capital (ROIC)
-38.56%
TTM Avg
-39.74%
3Y Avg
-42.41%
5Y Avg
-37.88%
Market Cap
$169.20M
Return on Invested Capital (ROIC)
-42.11%
TTM Avg
-29.16%
3Y Avg
-30.37%
5Y Avg
-28.38%
Market Cap
$156.90M
Return on Invested Capital (ROIC)
-13.94%
TTM Avg
-16.11%
3Y Avg
-25.11%
5Y Avg
-17.04%
Market Cap
$169.76M
Return on Invested Capital (ROIC)
-58.55%
TTM Avg
-41.33%
3Y Avg
-32.67%
5Y Avg
-48.97%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quanterix Corporation (QTRX) | $163.22M | -49.08% | -36.43% | -23.39% | -19.37% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $162.60M | N/A | -138.87% | -97.17% | -81.85% |
| PepGen Inc. (PEPG)vs › | $161.52M | -57.59% | -65.44% | -58.20% | -45.38% |
| OptimizeRx Corp. (OPRX)vs › | $166.08M | 4.92% | -1.65% | -7.20% | -5.46% |
| Coherus Oncology, Inc. (CHRS)vs › | $159.52M | -135.38% | -110.80% | -91.23% | -65.73% |
| Minerva Neurosciences, Inc. (NERV)vs › | $158.63M | -38.56% | -39.74% | -42.41% | -37.88% |
| Nkarta, Inc. (NKTX)vs › | $169.20M | -42.11% | -29.16% | -30.37% | -28.38% |
| Inogen, Inc. (INGN)vs › | $156.90M | -13.94% | -16.11% | -25.11% | -17.04% |
| MediWound Ltd. (MDWD)vs › | $169.76M | -58.55% | -41.33% | -32.67% | -48.97% |
| Neuronetics, Inc. (STIM)vs › | $155.53M | -22.15% | -29.24% | -31.64% | -30.48% |
ROIC
-49.1%
ROE
-51.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -49.08% |
| 2026-03-31 | -37.83% |
| 2025-12-31 | -36.24% |
| 2025-09-30 | -31.51% |
| 2025-06-30 | -27.48% |
| 2025-03-31 | -17.92% |
| 2024-12-31 | -14.43% |
| 2024-09-30 | -14.63% |
| 2024-06-30 | -14.95% |
| 2024-03-31 | -14.35% |
| 2023-12-31 | -12.51% |
| 2023-09-30 | -13.64% |
| 2023-06-30 | -19.52% |
| 2023-03-31 | -23.21% |
| 2022-12-31 | -25.12% |
| 2022-09-30 | -23.83% |
| 2022-06-30 | -17.32% |
| 2022-03-31 | -14.16% |
| 2021-12-31 | -12.48% |
| 2021-09-30 | -10.10% |
| 2021-06-30 | -6.25% |
| 2021-03-31 | -5.88% |
| 2020-12-31 | -13.22% |
| 2020-09-30 | -13.64% |
| 2020-06-30 | -31.54% |
| 2020-03-31 | -28.81% |
| 2019-12-31 | -27.70% |
| 2019-09-30 | -25.11% |
| 2019-06-30 | -39.96% |
| 2019-03-31 | -69.35% |
| 2018-12-31 | -63.13% |
| 2018-09-30 | -52.24% |
| 2018-06-30 | -45.07% |
| 2018-03-31 | -39.09% |
| 2017-12-31 | -33.73% |
| 2017-09-30 | -144.83% |
| 2017-06-30 | -102.18% |
| 2017-03-31 | -107.06% |
| 2016-12-31 | -80.23% |
